Home > Newsletters > Washington Drug Letter > Public Citizen Calls for Boxed Warning on Top-Selling Hypertension Drugs
Washington Drug Letter
Oct. 15, 2012 | Vol. 44 No. 41
Public Citizen Calls for Boxed Warning on Top-Selling Hypertension Drugs
Public Citizen is urging the FDA to require boxed warnings on the labels of many top-selling hypertension drugs, including angiotensin-converting enzyme (ACE) inhibitors, angiotensin II receptor blockers (ARBs) and Novartis’ aliskiren, to warn against their use in combination.
ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnewsAll rights reserved. Do not duplicate or redistribute in any form.